The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma.
Saved in:
| Title: | The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma. |
|---|---|
| Authors: | Albrecht T; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Goeppert B; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Brinkmann F; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Charbel A; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Zhang Q; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Schreck J; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Wilhelm N; Tissue Bank of the National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany., Singer S; Institute of Pathology and Neuropathology, Eberhard-Karls University, 72076 Tübingen, Germany., Köhler BC; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany., Springfeld C; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany., Mehrabi A; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany., Schirmacher P; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Kühl AA; Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, iPATH.Berlin, 12203 Berlin, Germany., Vogel MN; Diagnostic and Interventional Radiology, Thoraxklinik at Heidelberg University Hospital, 69126 Heidelberg, Germany., Jansen H; Institute for Medical Immunology, Campus Virchow, Charité, Augustenburger Platz 1, 13353 Berlin, Germany., Utku N; Institute for Medical Immunology, Campus Virchow, Charité, Augustenburger Platz 1, 13353 Berlin, Germany., Roessler S; Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany. |
| Source: | Cancers [Cancers (Basel)] 2021 Dec 14; Vol. 13 (24). Date of Electronic Publication: 2021 Dec 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers13246272 |
